Übersicht über laufende und abgeschlossene Studien

Nummer
Recruitment ongoing

AFORCE-1

Markers for early diagnosis of cancer growth
Markers for early diagnosis of cancer growth
Informationen zur Studie

This multicenter, prospective, group-controlled study for early cancer detection is intended to verify whether a new blood test is suitable for distinguishing malignant tumours (cancers) from other tumories/diseases and control subjects.

The AFORCE-1 study aims to test the accuracy of this blood test before it can later be used in diagnostics. This includes patients with suspected tumours (10 most common types of tumours) and healthy volunteers. The development of suspected tumours is observed over a period of 12 months and compared with the results of the blood test for early cancer detection at the end of the study.

The study was rated positively on 05.04.2024 by the Colorectal Cancer Study Board of the German Cancer Society. It therefore meets the criteria for recognition of the study within the certification system and is included in studybox (www.studybox.de) listed. The registration number is: ST-U178.

Recruitment ongoing

ORSOME-II study

Digital application for knee rehabilitation
Digital application for knee rehabilitation
Informationen zur Studie

As part of this nationwide scientific investigation, it is intended to test whether rehabilitation after surgical treatment of a knee joint injury with a digital application in addition to sole physiotherapy is better than physical therapy alone (current standard of care).

The digital application is a medical device that enhances knee rehabilitation through a combination of tests, a training program and a knowledge database. The app consists of a motion sensor and an app and enables a supplementary, independent and flexible continuation of knee joint rehabilitation from home. The registration is carried out by doctors, after which the follow-up is digital.

Recruitment completed

Smoke-free study

Digital smoking cessation application
Digital smoking cessation application
Informationen zur Studie

This nationwide scientific study aims to test the effectiveness of a digital health application (DiGA) for quitting smoking. It is a medical device that provides scientifically based elements for quitting smoking.

The app contains elements that can increase motivation to stop smoking and make it easier to successfully deal with smoking cravings. The study is carried out completely digitally.

Recruitment ongoing

heart health

Early diagnosis of heart disease
Early diagnosis of heart disease
Informationen zur Studie

Several international prospective, randomized and blinded studies and in a registry study are investigating whether a three-dimensional derivative of the heart current curve followed by AI-based analysis can assess people's risk of suffering from a heart circulatory disorder. It is a medical device.

A major field study funded by the NHS is taking place in the UK. The registration is carried out by doctors, after which, depending on clinical necessity, the follow-up is either on-site or contactlessly digital.

Recruitment completed

Losing weight app

Digital weight loss application
Digital weight loss application
Informationen zur Studie

This nationwide scientific study aims to verify the effectiveness of digital therapy for treating severe obesity (Digital Health Application — DiGA) and to investigate the impact on the quality of life.

It is a certified medical device. The study is being carried out completely digitally throughout Germany.

Recruitment planned

BLISS study

Digital snoring treatment application
Digital snoring treatment application
Informationen zur Studie

Relieve snoring with an app and exercises - available soon with more information

MEDIACC -das unabhängige wissenschaftliche Institut hinter der Studie

Gemeinsam für eine bessere medizinische Versorgung

MEDIACC ist ein unabhängiges wissenschaftliches Institut. Wir sind Experten im Bereich medizinischer Studien und unterstützen Hersteller von Medizinprodukten dabei, bestmögliche klinische Studien durchzuführen, damit bedeutsame Produkte die Medizin von morgen verbessern können.

Über 350

Abgeschlossene Einzelprojekte

Mehr als 4000

Patientinnen und Patienten nahmen an unseren digitalen Studien teil

57

Klinische Studien, 3 davon komplett digital